4//SEC Filing
Bruguera Carolyn M 4
Accession 0001209191-10-047739
CIK 0001028318other
Filed
Sep 27, 8:00 PM ET
Accepted
Sep 28, 6:03 PM ET
Size
28.1 KB
Accession
0001209191-10-047739
Insider Transaction Report
Form 4
Bruguera Carolyn M
Vice Pres. & General Counsel
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$14.21/sh−8,856$125,844→ 0 totalExercise: $9.19Exp: 2019-05-26→ Common Stock (8,856 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$3.58/sh−5,417$19,393→ 0 totalExercise: $19.82Exp: 2018-01-14→ Common Stock (5,417 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$4.95/sh−19,514$96,594→ 0 totalExercise: $18.45Exp: 2016-11-22→ Common Stock (19,514 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$11.98/sh−2,162$25,901→ 0 totalExercise: $11.42Exp: 2018-05-14→ Common Stock (2,162 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$14.78/sh−46,259$683,708→ 0 totalExercise: $8.62Exp: 2015-11-16→ Common Stock (46,259 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$11.98/sh−17,838$213,699→ 0 totalExercise: $11.42Exp: 2018-05-14→ Common Stock (17,838 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$14.21/sh−16,144$229,406→ 0 totalExercise: $9.19Exp: 2019-05-26→ Common Stock (16,144 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$3.58/sh−14,583$52,207→ 0 totalExercise: $19.82Exp: 2018-01-14→ Common Stock (14,583 underlying) - Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$14.78/sh−3,741$55,292→ 0 totalExercise: $8.62Exp: 2015-11-16→ Common Stock (3,741 underlying) - Disposition to Issuer
Common Stock
2010-09-27−9,182→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2010-09-27$4.95/sh−5,486$27,156→ 0 totalExercise: $18.45Exp: 2016-11-22→ Common Stock (5,486 underlying)
Footnotes (3)
- [F1]3,067 shares of common stock were purchased under Micrus Endovascular Corporation's 2005 Employee Stock Purchase Plan as follows: 1,111 shares on September 30, 2009, 1,111 shares on March 31, 2010 and 845 shares on September 23, 2010.
- [F2]Pursuant to the Agreement and Plan of Merger, dated as of July 11, 2010, between Micrus Endovascular Corporation, Johnson & Johnson and Cope Acquisition Corp., each share of common stock held by the reporting person was converted into the right to receive $23.40 in cash, without interest.
- [F3]Pursuant to the Agreement and Plan of Merger, dated as of July 11, 2010, between Micrus Endovascular Corporation, Johnson & Johnson and Cope Acquisition Corp., this stock option was converted into the right to receive an amount in cash per share subject to the stock option equal to the excess of the per share merger consideration of $23.40 over the per share exercise price of such stock option, without interest.
Documents
Issuer
MICRUS ENDOVASCULAR CORP
CIK 0001028318
Entity typeother
Related Parties
1- filerCIK 0001344521
Filing Metadata
- Form type
- 4
- Filed
- Sep 27, 8:00 PM ET
- Accepted
- Sep 28, 6:03 PM ET
- Size
- 28.1 KB